Gregory M Lucas

Professor

19972020
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1997 2020

1997
Vancomycin
Bacteremia
Central Venous Catheters
Enterococcus
Intensive Care Units
1998
Vancomycin
Bacteremia
Metronidazole
Central Venous Catheterization
APACHE
1999
Highly Active Antiretroviral Therapy
Drug-Related Side Effects and Adverse Reactions
HIV-1
RNA
Protease Inhibitors
Salvage Therapy
Highly Active Antiretroviral Therapy
Education
Holidays
HIV

Primary cutaneous Aspergillus nidulans infection associated with a Hickman catheter in a patient with neutropenia

Lucas, G. M., Tucker, P. & Merz, W. G., 1999, In : Clinical Infectious Diseases. 29, 6, p. 1594-1596 3 p.

Research output: Contribution to journalArticle

Dermatomycoses
Aspergillus nidulans
Aspergillosis
Neutropenia
Catheterization
2000
AIDS-Related Opportunistic Infections
Pneumococcal Infections
Human Herpesvirus 8
Opportunistic Infections
Cytomegalovirus Infections
Highly Active Antiretroviral Therapy
Drug-Related Side Effects and Adverse Reactions
Immune System
Acquired Immunodeficiency Syndrome
HIV
2001
efavirenz
Saquinavir
Ritonavir
Protease Inhibitors
HIV-1

Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection

Lucas, G. M., Cheever, L. W., Chaisson, R. E. & Moore, R. D., Jul 1 2001, In : Journal of Acquired Immune Deficiency Syndromes. 27, 3, p. 251-259 9 p.

Research output: Contribution to journalArticle

Street Drugs
HIV Infections
Highly Active Antiretroviral Therapy
HIV-1
Drug Users
Directly Observed Therapy
Antitubercular Agents
Anti-HIV Agents
HIV Infections
Tuberculosis
AIDS-Related Lymphoma
Kaposi's Sarcoma
Highly Active Antiretroviral Therapy
CD4 Lymphocyte Count
Lymphoma
Antitubercular Antibiotics
AIDS-Related Opportunistic Infections
Drug Administration Schedule
Drug Approval
Anti-HIV Agents
Salvage Therapy
Highly Active Antiretroviral Therapy
Multiple Drug Resistance
Protease Inhibitors
Acquired Immunodeficiency Syndrome
Virus Diseases
HIV
Therapeutics
Directly Observed Therapy
Community-Institutional Relations
AIDS-Related Opportunistic Infections
Drug Administration Schedule
Cryptococcal Meningitis
Anti-HIV Agents
Intracranial Pressure
Viral Drug Resistance
Directly Observed Therapy
Anti-HIV Agents
AIDS Vaccines
Syphilis
Alcoholism
Substance-Related Disorders
HIV-1
Therapeutics
Alcohols
Anti-HIV Agents
Salvage Therapy
Combination Drug Therapy
Viral Load
Immunotherapy
2003
Highly Active Antiretroviral Therapy
HIV-1
Cohort Studies
Survival
Hyperlipidemias
Lipodystrophy
Highly Active Antiretroviral Therapy
Osteoporosis
Cardiovascular Diseases
Kidney
2004

Adherence to antiretroviral therapy: an update of current concepts.

Lucas, G. M., Wu, A. W. & Cheever, L. W., Dec 2004, In : Joint Commission Journal on Quality and Patient Safety. 1, 4, p. 172-180 9 p.

Research output: Contribution to journalArticle

HIV
Therapeutics
Medication Adherence
Drug Resistance
HIV Infections
Diffusion of Innovation
Opioid-Related Disorders
Buprenorphine
Narcotic Antagonists
Deglutition
Methadone
HIV-1
Drug Users
Therapeutics
Injections

Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: A 12-year cohort study

Lucas, G. M., Eustace, J. A., Sozio, S. M., Mentari, E. K., Appiah, K. A. & Moore, R. D., Feb 20 2004, In : AIDS. 18, 3, p. 541-546 6 p.

Research output: Contribution to journalArticle

AIDS-Associated Nephropathy
compound A 12
Highly Active Antiretroviral Therapy
HIV-1
Cohort Studies

Relationship between drug resistance and HIV-1 disease progression or death in patients undergoing resistance testing

Lucas, G. M., Gallant, J. E. & Moore, R. D., Jul 23 2004, In : AIDS. 18, 11, p. 1539-1548 10 p.

Research output: Contribution to journalArticle

Drug Resistance
Disease Progression
HIV-1
Mutation
Highly Active Antiretroviral Therapy
2005
Viral Drug Resistance
Anti-HIV Agents
Salvage Therapy
HIV Infections
Pharmaceutical Preparations
Highly Active Antiretroviral Therapy
HIV
Baltimore
Patient Care
RNA
Viral Drug Resistance
Drug Resistance
Disease Progression
HIV
Highly Active Antiretroviral Therapy

Effectiveness of highly active antiretroviral therapy among injection drug users with late-stage human immunodeficiency virus infection

Vlahov, D., Galai, N., Safaeian, M., Galea, S., Kirk, G. D., Lucas, G. M. & Sterling, T. R., Jun 1 2005, In : American Journal of Epidemiology. 161, 11, p. 999-1012 14 p.

Research output: Contribution to journalArticle

Highly Active Antiretroviral Therapy
Virus Diseases
Drug Users
HIV
Injections
Viral Drug Resistance
HIV Protease Inhibitors
Reverse Transcriptase Inhibitors
CD4 Lymphocyte Count
Viral Load
2006

Buprenorphine use: The international experience

Carrieri, M. P., Amass, L., Lucas, G. M., Vlahov, D., Wodak, A. & Woody, G. E., Dec 15 2006, In : Clinical Infectious Diseases. 43, SUPPL. 4

Research output: Contribution to journalArticle

Buprenorphine
Virus Diseases
Methadone
Heroin
HIV
Methadone
Drug Users
HIV
Injections
Highly Active Antiretroviral Therapy
Highly Active Antiretroviral Therapy
Street Drugs
Virus Diseases
Longitudinal Studies
Disease Progression
Endocarditis
HIV
Incidence
Highly Active Antiretroviral Therapy
Drug Users

Initial strategies for integrating buprenorphine into HIV care settings in the United States

Sullivan, L. E., Bruce, R. D., Haltiwanger, D., Lucas, G. M., Eldred, L., Finkelstein, R. & Fiellin, D. A., Dec 15 2006, In : Clinical Infectious Diseases. 43, SUPPL. 4

Research output: Contribution to journalArticle

Buprenorphine
HIV
Virus Diseases
Substance-Related Disorders
Community-Institutional Relations

Invasive pneumococcal disease in a cohort of HIV-infected adults: Incidence and risk factors, 1990-2003

Barry, P. M., Zetola, N., Keruly, J. C., Moore, R. D., Gebo, K. & Lucas, G. M., Feb 2006, In : AIDS. 20, 3, p. 437-444 8 p.

Research output: Contribution to journalArticle

HIV
Confidence Intervals
Incidence
Highly Active Antiretroviral Therapy
CD4 Lymphocyte Count

Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic

Mehta, S. H., Lucas, G. M., Mirel, L. B., Torbenson, M., Higgins, Y., Moore, R. D., Thomas, D. L. & Sulkowski, M., Nov 2006, In : AIDS. 20, 18, p. 2361-2369 9 p.

Research output: Contribution to journalArticle

Hepatitis C
Antiviral Agents
Hepacivirus
HIV
Referral and Consultation
2007

Adherence, drug use, and treatment failure in a methadone-clinic-based program of directly administered antiretroviral therapy

Lucas, G. M., Mullen, B. A., McCaul, M. E., Weidle, P. J., Hader, S. & Moore, R. D., Aug 2007, In : AIDS Patient Care and STDs. 21, 8, p. 564-574 11 p.

Research output: Contribution to journalArticle

Methadone
Treatment Failure
Pharmaceutical Preparations
Therapeutics
HIV

Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST)

Spire, B., Lucas, G. M. & Carrieri, M. P., Aug 2007, In : International Journal of Drug Policy. 18, 4, p. 262-270 9 p.

Research output: Contribution to journalArticle

Opiate Substitution Treatment
Drug Users
substitution
HIV
drug

Cocaine use and hypertensive renal changes in HIV-infected individuals

Fine, D. M., Garg, N., Haas, M., Rahman, M. H., Lucas, G. M., Scheel, P. J. & Atta, M., Nov 2007, In : Clinical Journal of the American Society of Nephrology. 2, 6, p. 1125-1130 6 p.

Research output: Contribution to journalArticle

Cocaine
HIV
Kidney
Biopsy
Odds Ratio
Highly Active Antiretroviral Therapy
Drug Users
Disease Progression
HIV
drug
Renal Replacement Therapy
Chronic Renal Insufficiency
African Americans
Chronic Kidney Failure
Highly Active Antiretroviral Therapy
Substance-Related Disorders
Highly Active Antiretroviral Therapy
HIV
Virus Diseases
Drug Users
Baltimore
Renal Replacement Therapy
Highly Active Antiretroviral Therapy
African Americans
HIV-1
2008

Antiretroviral Nephrotoxicities

Atta, M., Deray, G. & Lucas, G. M., Nov 2008, In : Seminars in Nephrology. 28, 6, p. 563-575 13 p.

Research output: Contribution to journalArticle

HIV-1
Kidney
Kidney Diseases
Virus Diseases
Dyslipidemias
Pancreatitis
Hospitalization
HIV
Incidence
Highly Active Antiretroviral Therapy
Chronic Renal Insufficiency
Chronic Kidney Failure
Disease Progression
African Americans
HIV